A dengue vaccine from Sanofi was approved in the U.S.
Sanofi SA’s dengue vaccine was approved in the U.S., the first treatment cleared by American regulators to protect against the mosquito-borne viral infection.
The vaccine, Dengvaxia, was approved by the Food and Drug Administration to treat people aged 9 to 16 with a laboratory-confirmed prior infection who live in areas where the disease occurs regularly through the year.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
Sanofi wins U.S. approval to sell dengue vaccine but with major restrictionsThe U.S. Food and Drug Administration on Wednesday gave Sanofi SA's dengue ...
और पढो »
Sanofi wins U.S. approval to sell dengue vaccine but with major restrictionsThe U.S. Food and Drug Administration on Wednesday gave Sanofi SA's dengue ...
और पढो »
Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis treatmentBausch Health, formerly known as Valeant Pharmaceuticals, said Thursday that it and its dermatology business, Ortho Dermatologics received approval from the FDA for a lotion to treat plaque psoriasis.
और पढो »
Bolton gets testy when pressed about Trump getting tough on RussiaAn interview with national security adviser John Bolton briefly went off the rails when Bolton accused his interviewer of attempting to steer the discussion about an uprising in Venezuela to Russian collusion
और पढो »
Merck steps up U.S. measles vaccine production with increased demandMerck & Co said on Wednesday it has increased production of the measles vaccine ...
और पढो »
'Only medical exemptions': Buttigieg campaign clarifies vaccine position after uproarButtigieg's campaign tried to clarify the mayor's position on vaccines after earlier comments indicated support for personal or religious exemptions.
और पढो »
Merck raises full-year forecasts as vaccines power profit beatMerck & Co Inc reported higher-than-expected first-quarter profit on Tuesday on ...
और पढो »